Search Results 241-250 of 17155 for monoclonal antibody

  1. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

    Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate (ADC) containing humanized anti- B-cell maturation antigen (BCMA) monoclonal antibody (mAb).

  2. Pediatric Brain Tumor Surgery Clinical Trials - Mayo Clinic Research

    Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...

  3. Publications - Leigh L. Speicher, M.D., M.P.H. - Mayo Clinic

    ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Wert K, Donaldson AM, Dinh TA ...

  4. Eculizumab-aeeb (intravenous route) - Side effects & uses - Mayo Clinic

    Eculizumab-aeeb injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program ...

  5. Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells. Biological therapies, such as brentuximab ...

  6. Health Topics - Mayo Clinic News Network

    Monoclonal antibody treatment helps couple recover quickly from COVID-19. Dan Lea. February 23, 2021. COVID-19. Changes for visitors at Mayo Clinic in Rochester.

  7. Muromonab-cd3 (intravenous route) - Side effects & dosage - Mayo Clinic

    Muromonab-CD3 is a monoclonal antibody. It is used to reduce the body's natural immunity in patients who receive organ (for example, kidney) transplants ...

  8. Eosinophilic esophagitis - Diagnosis and treatment - Mayo Clinic

    Monoclonal antibodies. The Food and Drug Administration (FDA) recently ... Dupilumab is a type of medicine known as a monoclonal antibody. It works to ...

  9. Penpulimab-kcqx (intravenous route) - Side effects & uses - Mayo Clinic

    Penpulimab-kcqx is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

  10. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

    Imiquimod may stimulate the immune system. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.